KẾT QUẢ ĐIỀU TRỊ THỞ OXY DÒNG CAO TRONG VIÊM TIỂU PHẾ QUẢN Ở TRẺ NHŨ NHI

Abstract

Objects: Evaluate the effectiveness of high-flow nasal cannula therapy (HFNC) in infants with bronchiolitis admitted to the emergency department of City Children's Hospital during the period from January 2024 to June 2024.
Methods: Prospective descriptive study of cases series.
Results: There were 30 children with bronchiolitis admitted to the emergency department at City Children's Hospital during the period from January 2024 - June 2024, receiving high flow nasal cannula oxygen therapy (HFNC) after failure with standard oxygen therapy, average age of 6.8 months old, and
male/female ratio: 1.1/1. Clinical manifestations before HFNC breathing included 93.3% tachypnea, 86.7% chest indrawing, 100% wheezing, 80% snoring sounds, 46.7% whistling sounds, 13.3% nostril flaring, 66.7% tachycardia, modified bronchiolitis score of 7.1 ± 1.3, SpO2 : 91.3 ± 1.5%. The results showed
improvement in infants’ respiratory failure such as tachypnea rate, chest indrawing, improved modified bronchiolitis score, SpO2, at 6 hours and 24 hours of HFNC. The successful treatment rate for HFNC was 86.7%. HFNC breathing time 48.7 ± 3.4 hours. No complications of HFNC ventilation and no deaths were documented.
Conclusions: Research shows that respiratory support with HFNC for infants with bronchiolitis failing to standard of oxygen therapy improves respiratory status as well as clinical outcomes of patients.